Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

ICCC
Immucell Corp
stock NASDAQ

At Close
May 7, 2025 3:59:30 PM EDT
5.19USD0.000%(0.00)5,490
0.00Bid   0.00Ask   0.00Spread
Pre-market
May 7, 2025 9:24:30 AM EDT
5.07USD-2.312%(-0.12)630
After-hours
May 7, 2025 4:34:30 PM EDT
5.20USD+0.193%(+0.01)200
OverviewHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 5, 2022
06:36AM EST  ImmuCell FY Sales Up By About 25% To $19.2 Mln   RTTNews
06:32AM EST  ImmuCell Reports Prelim. FY21 Sales $19.2M, Up 25% YoY   Benzinga
06:30AM EST  ImmuCell Corporation (Nasdaq:ICCC) (ImmuCell or the Company), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, todayannounced preliminary, unaudited sales results for the year ended December 31, 2021.   GlobeNewswire Inc
Nov 15, 2021
06:01PM EST  ImmuCell Q3 EPS $0.02 Up From $(0.04) YoY, Sales $5.15M Up From $3.72M YoY   Benzinga
11:07AM EST  Earnings Scheduled For November 15, 2021   Benzinga
10:37AM EST  The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More   Benzinga
Oct 6, 2021
06:33AM EDT  ImmuCell Prelim. Q3 Sales $5.2M, Up 38% YoY   Benzinga
06:30AM EDT  ImmuCell Corporation (Nasdaq:ICCC) (ImmuCell or the Company), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, todayannounced preliminary, unaudited sales results for the third quarter ended September 30, 2021.   GlobeNewswire Inc
Sep 14, 2021
06:30AM EDT  Raffael Lichdi, DVM Joins ImmuCells Sales &   GlobeNewswire Inc
Aug 31, 2021
09:31PM EDT  Pomerantz LLP is investigating claims on behalf of investors of ImmuCell Corporation (ImmuCell or the Company) (NASDAQ:ICCC). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.   GlobeNewswire Inc
Aug 25, 2021
06:05AM EDT  Mid-Day Market Update: Crude Oil Rises Over 2%; Theravance Biopharma Shares Slide   Benzinga
Aug 24, 2021
02:45PM EDT  Mid-Afternoon Market Update: Nasdaq Rises 75 Points; Palo Alto Networks Shares Jump On Upbeat Earnings   Benzinga
12:18PM EDT  Mid-Day Market Update: Crude Oil Rises Over 2%; Theravance Biopharma Shares Slide   Benzinga
06:37AM EDT  ImmuCell Corporation Announces FDA Has Issued Technical Section Incomplete Letter Coveirng Chemistry, Manufacturing And Controls (CMC) Technical Section For Re-Tain   Benzinga
06:30AM EDT  ImmuCell Required to Prepare Second Submission of Final Major   GlobeNewswire Inc
Aug 12, 2021
04:21PM EDT  ImmuCell Q2 EPS $0.02 Up From $(0.11) YoY, Sales $4.54M Miss $5.40M Estimate   Benzinga
04:05PM EDT  ImmuCell Corporation (Nasdaq:ICCC) (ImmuCell or the Company), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, todayannounced its unaudited financial results for the quarter ended June 30, 2021.   GlobeNewswire Inc
08:09AM EDT  The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma   Benzinga
04:14AM EDT  Earnings Scheduled For August 12, 2021   Benzinga
Aug 9, 2021
11:07AM EDT  The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight   Benzinga
Aug 5, 2021
06:30AM EDT  ImmuCell Corporation (Nasdaq:ICCC) (ImmuCell or the Company), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, expects to report unaudited financial results for the quarter ended June 30, 2021 after the market closes on Thursday, August 12, 2021.   GlobeNewswire Inc
Jul 7, 2021
07:41AM EDT  The Daily Biotech Pulse: Opiant Spikes On Data, OncoSec Rallies On Merck Collaboration, XBiotech Special Dividend   Benzinga
07:24AM EDT  ImmuCell Sees $1.6 Mln Increase In Total Product Sales To About $4.5 Mln   RTTNews
07:07AM EDT  ImmuCell Sees Q2 Sales ~$4.5M Vs. $3.26M Est.   Benzinga
07:00AM EDT  ImmuCell Corporation (Nasdaq:ICCC) (ImmuCell or the Company), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, todayannounced preliminary, unaudited sales results for the second quarter ended June 30, 2021.   GlobeNewswire Inc
May 19, 2021
12:00PM EDT  ImmuCell Corporation (Nasdaq:ICCC) (ImmuCell or the Company), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, todayannounced that its 2021 Annual Meeting of Stockholders will be conducted virtually.   GlobeNewswire Inc
May 13, 2021
05:00PM EDT  ImmuCell Q1 EPS $(0.06) Misses $0.05 Estimate, Sales $4.11M Miss $5.40M Estimate   Benzinga
04:05PM EDT  ImmuCell Corporation (Nasdaq:ICCC) (ImmuCell or the Company), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, todayannounced its unaudited financial results for the quarter ended March 31, 2021.   GlobeNewswire Inc
08:10AM EDT  The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use   Benzinga
04:15AM EDT  Earnings Scheduled For May 13, 2021   Benzinga
May 6, 2021
01:41PM EDT  ImmuCell Corporation (Nasdaq:ICCC) (ImmuCell or the Company), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, expects to report unaudited financial results for the quarter ended March 31, 2021 after the market closes on Thursday, May 13, 2021.   GlobeNewswire Inc
Apr 14, 2021
05:16PM EDT  ImmuCell Corporation (Nasdaq:ICCC) (ImmuCell or the Company), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, todayannounced that it has closed an equity investment.   GlobeNewswire Inc
Apr 7, 2021
08:11AM EDT  ImmuCell Reports Prelim. Q1 Results: Total Product Sales ~$4.1M, Down 16% Year Over Year, Order Backlog ~$1.8M As Of Dec. 31, 2020   Benzinga
08:00AM EDT  ImmuCell Corporation (Nasdaq:ICCC) (ImmuCell or the Company), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, todayannounced preliminary, unaudited sales results for the first quarter ended March 31, 2021.   GlobeNewswire Inc
Feb 23, 2021
07:25AM EST  The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts   Benzinga
Feb 22, 2021
04:09PM EST  ImmuCell Q4 EPS $0.03 Up From $(0.04) YoY, Sales $3.74M Miss $4.00M Estimate   Benzinga
04:04PM EST  ImmuCell Makes Important Regulatory Submission and Announces   GlobeNewswire Inc
04:02AM EST  Earnings Scheduled For February 22, 2021   Benzinga
Feb 16, 2021
01:42PM EST  ImmuCell Corporation (Nasdaq:ICCC) (ImmuCell or the Company), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, will report unaudited financial results for the year ended December 31, 2020 after the market closes on Monday, February 22, 2021.   GlobeNewswire Inc
Jan 28, 2021
08:03AM EST  The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO   Benzinga
Jan 27, 2021
07:36AM EST  The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement   Benzinga
Jan 21, 2021
08:05AM EST  The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping   Benzinga
Jan 7, 2021
08:17AM EST  ImmuCell Expect 12% Increase In Total Product Sales To $15.3 Mln During Year Ended Dec 31, 2020   RTTNews
08:04AM EST  ImmuCell Sees FY20 Sales ~$15.3M Vs. $15.14M Est.   Benzinga
08:00AM EST  ImmuCell Corporation (Nasdaq:ICCC) (ImmuCell or the Company), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, todayannounced preliminary, unaudited sales results for the year ended December 31, 2020.   GlobeNewswire Inc
Dec 15, 2020
04:05PM EST  ImmuCell Corporation (Nasdaq:ICCC) (ImmuCell or the Company), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, todayannounced a restructuring of its bank debt.   GlobeNewswire Inc
Nov 12, 2020
04:20PM EST  ImmuCell Q3 EPS $(0.04) Beats $(0.08) Estimate, Sales $3.72M Beat $3.27M Estimate   Benzinga
07:44AM EST  The Daily Biotech Pulse: AstraZeneca's Cancer Drug Flunks COVID-19 Studies, Five Prime On a Roll, Morphosys, Xencor, Incyte Strike Cancer Deal   Benzinga
04:18AM EST  Earnings Scheduled For November 12, 2020   Benzinga
Nov 8, 2020
03:58PM EST  The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions   Benzinga
12:47PM EST  The Week Ahead In Biotech: Earnings, Conference Presentations And IPOs   Benzinga
Oct 6, 2020
08:07AM EDT  ImmuCell Reports Q3 Prelim. Sales of $3.7M, Beats $3.27M Est.   Benzinga
08:00AM EDT  ImmuCell Corporation (Nasdaq:ICCC) (ImmuCell or the Company), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef calves, todayannounced preliminary, unaudited sales results for the third quarter ended September 30, 2020.   GlobeNewswire Inc
Aug 12, 2020
04:12PM EDT  ImmuCell Q2 EPS $(0.11) Misses $(0.10) Estimate, Sales $2.97M Up From $2.71M YoY   Benzinga
04:05PM EDT  ImmuCell Corporation (Nasdaq:ICCC) (ImmuCell or the Company), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef calves, todayannounced unaudited financial results for the quarter ended June 30, 2020.   GlobeNewswire Inc
04:21AM EDT  Earnings Scheduled For August 12, 2020   Benzinga
Jul 13, 2020
11:27AM EDT  Aegis Capital Initiates Coverage On ImmuCell with Buy Rating, Announces Price Target of $14   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC